What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Kiniksa Pharmaceuticals International, plc KNSA Net Change in Cash

Net Change in Cash at other companies

Ligand PharmaceuticalsLGND

-$59.83M-146%

Apogee Therapeutics, Inc.APGE

$320.25M+1,018%

BridgeBio PharmaBBIO

$309.88M+321%

Ionis PharmaceuticalsIONS

-$198.88M-999%

Ultragenyx PharmaceuticalRARE

-$247M-449%

LQD

Liquidia CorporationLQDA

$32.11M+578%

Other financials

Income statement

See full

Revenue$214.3M+55.5%

Gross profit$193.5M+61.3%

Operating income$29.3M+121%

Net income$22.6M+165%

EPS (diluted)$0.27+145%

Balance sheet

See full

Cash & equivalents$190.0M+20.9%

Total debt$9.0M-9.0%

Total equity$605.7M+32.4%

Total assets$825.3M+37.7%

Cash flow

See full

Operating cash flow$50.2M+125%

CapEx$161.0K+62.6%

Free cash flow$50.0M+125%

Valuation

See full

Market cap$4.58B+128%

Profitability

See full

Gross margin89.3%+3.5pp

Operating margin12.4%+10.2pp

Net margin9.7%+7.6pp

FCF margin21.8%+12.2pp

Returns & leverage

See full

Return on equity13.7%+11.3pp

Debt / equity0×0.0×

Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's net change in cash?: Kiniksa Pharmaceuticals International, plc (KNSA) reported net change in cash of $24.36M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's net change in cash changed year-over-year?: Kiniksa Pharmaceuticals International, plc's net change in cash increased by 192.1% year-over-year, from -$26.45M to $24.36M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.